TABLE 1.
Folate |
Folic acid |
||||
Sex/age groups | n | Value, DFEs | Less than the EAR, % | Value, μg | Above the UL, % |
All participants, y | |||||
≥19 | 4878 | 763 ± 7 | 6.8 ± 0.9 | 314 ± 4 | 1.6 ± 0.2 |
19–30 | 1083 | 707 ± 19 | 6.5 ± 1.1 | 292 ± 9 | 1.2 ± 0.4 |
31–50 | 1587 | 745 ± 12 | 7.0 ± 0.9 | 302 ± 8 | 1.3 ± 0.4 |
51–70 | 1559 | 797 ± 16 | 6.1 ± 1.1 | 322 ± 6 | 1.7 ± 0.4 |
≥71 | 649 | 847 ± 20 | 7.7 ± 1.3 | 375 ± 12 | 2.7 ± 0.5 |
P-trend (age) | 0.0002 | 0.2537 | 0.005 | <0.0001 | |
Men, y | |||||
≥19 | 2469 | 817 ± 132 | 3.3 ± 0.52 | 326 ± 73 | 1.4 ± 0.4 |
19–30 | 575 | 767 ± 212 | 3.2 ± 0.93 | 308 ± 112 | 0.9 ± 0.5 |
31–50 | 798 | 789 ± 172 | 3.1 ± 0.63 | 305 ± 92 | 0.6 ± 0.2 |
51–70 | 769 | 857 ± 382 | 3.4 ± 0.63 | 337 ± 192 | 2.1 ± 0.9 |
≥71 | 327 | 943 ± 522 | 4.4 ± 1.03 | 422 ± 323 | 3.5 ± 0.93 |
P-trend (age) | 0.0015 | 0.3025 | 0.0018 | <0.0001 | |
Women, y | |||||
≥19 | 2409 | 711 ± 13 | 10.1 ± 1.7 | 302 ± 6 | 1.6 ± 0.2 |
19–30 | 508 | 635 ± 35 | 10.8 ± 2.0 | 274 ± 17 | 1.5 ± 0.5 |
31–50 | 789 | 702 ± 24 | 11.1 ± 1.7 | 299 ± 14 | 2.1 ± 0.6 |
51–70 | 790 | 747 ± 21 | 8.7 ± 1.9 | 308 ± 12 | 1.3 ± 0.4 |
≥71 | 322 | 770 ± 21 | 10.0 ± 2.1 | 341 ± 12 | 1.9 ± 0.7 |
P-trend (age) | 0.0006 | 0.1398 | 0.0065 | 0.2531 |
Values are means or percentages ± SEs unless otherwise indicated. The National Cancer Institute method was used to estimate the self-reported total usual folate and folic acid intake distributions and compliance with the DRI guidelines. SEs were estimated with the Taylor series linearization. Trends by age group and sex comparisons were tested with linear contrasts. DFE, dietary folate equivalent; DRI, Dietary Reference Intake; EAR, Estimated Average Requirement; UL, Tolerable Upper Intake Level.
Different from women: 2P < 0.001, 3P < 0.01.